Google's latest AI music model can create longer, higher-quality songs with better structure. But is the music any good, and ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

For people with near-total paralysis, the ability to communicate easily in real time is a challenge. For years, scientists have been working to remedy that by developing devices that can decode brain ...

Claude can now generate visuals when producing a response. (Anthropic) With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its ...

It starts as a normal “McAfee refund” call—fake charge, remote access, and the usual pressure. Then the scammer makes the fatal mistake: he connects in a way that lets the team flip access back onto ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Sanuj is a freelance tech journalist with over six years of experience covering smartphones, wearables, and consumer technology. He currently writes for Android Police, Tom's Guide, Android Central, ...

Random numbers are very important to us in this computer age, being used for all sorts of security and cryptographic tasks. [Theory to Thing] recently built a device to generate random numbers using ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...